| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.5 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.5 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |